Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Overweight 1Obesity 1Neoplasms 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Paclitaxel 16pembrolizumab 15Carboplatin 13Specimen Handling 9Magnetic Resonance Spectroscopy 8Biopsy 7Bevacizumab 7Fulvestrant 6olaparib 5Taxes 5Megestrol Acetate 5Doxorubicin 5Cisplatin 5trastuzumab deruxtecan 4dostarlimab 4Nivolumab 4Gemcitabine 4palbociclib 3durvalumab 3Progestins 3Oxaliplatin 3Medroxyprogesterone Acetate 3Leucovorin 3Letrozole 3Immunoglobulin G 3Fluorouracil 3Docetaxel 3Disulfides 3ribociclib 2pertuzumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endometrial Neoplasms × Estrogen Replacement Therapy × 30 days × Clear all
NCT07462663 2026-05-13

SHAPE-ENDO

Hospital Universitari de Bellvitge

Phase 4 Not yet recruiting
82 enrolled
GynecologicOther

Endometrial Hyperplasia, Neoplasms, Obesity, Endometrial Neoplasms, Overweight

Data powered by HemOnc (CC BY 4.0) Colophon âš¡